Michel Vaillant

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

Shyam Sundar, Prabhat Kumar Sinha, Madhukar Rai et al. · The Lancet · 2011 · 335 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +11

Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial

Nicholas Opoku, Didier Bakajika, Eric M. Kanza et al. · The Lancet · 2018 · 306 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial

Faustino Torrico, Joaquím Gascón, Lourdes Ortiz et al. · The Lancet Infectious Diseases · 2018 · 297 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Agreement Between 35 Published Frailty Scores in the General Population

Gloria Aguayo, Anne‐Françoise Donneau, Michel Vaillant et al. · American Journal of Epidemiology · 2017 · 267 citations · Full text

Medicine, Biostatistics, Geriatric Medicine +12

Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions

Federico Baldini, Johannes Hertel, Estelle Sandt et al. · BMC Biology · 2020 · 223 citations · Full text

Life Sciences, Microbiology, Neuroscience +17